Streamline Health Solns Q2 EPS $(0.07), Inline, Sales $5.99M Beat $5.20M Estimate
Streamline Health Solns Q2 EPS $(0.07), Inline, Sales $5.99M Beat $5.20M Estimate
Streamline Health Solns第二季度每股收益0.07美元,内联,销售额599万美元超过预期520万美元
Streamline Health Solns (NASDAQ:STRM) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The company reported quarterly sales of $5.99 million which beat the analyst consensus estimate of $5.20 million by 15.23 percent. This is a 108.93 percent increase over sales of $2.87 million the same period last year.
Streamline Health Solns(纳斯达克股票代码:STRM)公布季度亏损为每股0.07美元,符合分析师的普遍预期。该公司公布的季度销售额为599万美元,比分析师普遍预期的520万美元高出15.23%。这比去年同期287万美元的销售额增长了108.93个百分点。